ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 403

$760K Total Retail Price of All Prescriptions

Rank: 15 out of 403

385 Patients Receiving at Least One Drug in Part D
39%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 385 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 5,504 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 441 166 1 1
NEXIUM 354 152 2 18
ATORVASTATIN CALCIUM 344 152 3 5
METFORMIN HCL 337 128 4 8
AMLODIPINE BESYLATE 324 204 5 4
METOPROLOL TARTRATE 285 199 6 10
HYDROCODONE-ACETAMINOPHEN 276 131 S3 7 15
FUROSEMIDE 240 159 8 7
SIMVASTATIN 237 106 9 2
GABAPENTIN 216 102 10 17
OMEPRAZOLE 202 103 11 9
CHLORTHALIDONE 201 85 12 84
METOPROLOL SUCCINATE 169 73 13 11
PANTOPRAZOLE SODIUM 169 86 13 30
ATENOLOL 162 65 15 13
TRAZODONE HCL 161 68 16 25
OXYCODONE HCL-ACETAMINOPHEN 156 59 S2 17 89
TAMSULOSIN HCL 147 108 18 27
LEVOTHYROXINE SODIUM 146 50 19 3
JANUVIA 140 62 20 44
LOSARTAN POTASSIUM 137 77 21 21
HYDROCHLOROTHIAZIDE 131 51 22 6
PRAVASTATIN SODIUM 122 54 23 14
CRESTOR 120 41 24 19
CLOPIDOGREL 119 87 25 55
PROAIR HFA 117 33 26 40
DEXILANT 113 39 27 81
HYDROXYZINE PAMOATE 110 33 R 28 178
TRAMADOL HCL 105 50 29 28
OXYBUTYNIN CHLORIDE ER 98 25 30 119
PAROXETINE HCL 98 33 30 68
IBUPROFEN 96 36 32 93
CYMBALTA 96 30 32 43
ZOLPIDEM TARTRATE 93 43 34 16
SERTRALINE HCL 92 16 35 20
ALENDRONATE SODIUM 92 73 35 26
NAPROXEN 90 52 37 79
OXYCODONE-ACETAMINOPHEN 89 62 S2 38 45
FAMOTIDINE 87 20 39 73
PREDNISONE 86 38 40 34
INSULIN SYRINGE 84 41 41 145
RAMIPRIL 84 44 41 75
ISOSORBIDE MONONITRATE ER 81 46 43 62
RANITIDINE HCL 81 14 43 46
VENTOLIN HFA 79 48 45 109
ALLOPURINOL 79 57 45 31
RISPERIDONE 77 11 47 48
ADVAIR DISKUS 77 54 47 33
OXYCONTIN 77 29 S2 47 63
ENALAPRIL MALEATE 73 58 50 66
GLIPIZIDE ER 72 50 51 86
GLIPIZIDE 72 37 51 70
METOLAZONE 71 40 53 191
AZITHROMYCIN 70 28 54 49
SPIRIVA 70 53 54 35
ETODOLAC 68 12 56 227
LIPITOR 67 26 57 53
FENTANYL 66 27 S2 58 71
AMITRIPTYLINE HCL 64 26 R 59 131
PLAVIX 63 50 60 83
HYDROXYZINE HCL 59 21 R 61 241
NOVOLOG MIX 70-30 FLEXPEN 58 21 62 172
POTASSIUM CHLORIDE 57 43 63 37
LYRICA 55 0 64 116
BUPROPION HCL SR 54 0 65 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.